Table 2

Univariable Prognostic Association With MACE Stratified by Sex

Clinical CharacteristicsAll Patients (N = 405)Women (n = 168)Men (n = 237)
LR Chi-Square TestHR (95% CI)p ValueLR Chi-Square TestHR (95% CI)p ValueLR Chi-Square TestHR (95% CI)p Value
Age, yrs17.311.07 (1.03–1.1)<0.00017.951.07 (1.02–1.11)<0.0059.161.06 (1.02–1.11)<0.005
Female0.010.98 (0.49–1.93)0.95
Hypertension12.135.4 (2.09–13.96)0.00052.092.56 (0.71–9.19)0.159.9610.11 (2.35–43.51)<0.005
Diabetes4.232.05 (1.04–4.08)<0.050.951.78 (0.56–5.63)0.334.433.21 (0.93–5.32)0.07
Hyperlipidemia3.382.04 (0.95–4.4)0.071.181.84 (0.62–5.48)0.282.362.35 (0.79–6.99)0.12
Hx of MI13.943.56 (1.82–6.93)<0.000513.186.98 (2.45–19.91)<0.00054.052.44 (1.02–5.8)<0.05
Hx of PCI17.914.21 (2.16-8.18)<0.00013.343.29 (0.92–11.79)0.0714.595.56 (2.31–13.42)<0.0005
Hx of CABG1.021.63 (0.63–4.21)0.320.021.16 (0.15–8.89)0.891.231.85 (0.62–5.17)0.27
Early revascularization19.054.74 (2.36–9.56)<0.000110.466.79 (2.13–21.66)<0.00511.234.54 (1.87–11.01)<0.001
SCOREClinical26.511.11 (1.07–1.15)<0.000110.631.10 (1.04–1.16)<0.00515.691.12 (1.06–1.19)<0.0001
Electrocardiographic findings
 Left bundle branch block6.313.37 (1.31–8.73)0.010.061.28 (0.17–9.8)0.8110.386.12 (2.03–18.44)<0.005
 Significant Q waves6.932.69 (1.29–5.61)<0.057.314.95 (1.55–15.8)<0.012.22.05 (0.79–5.31)0.14
 Resting ST changes22.665.19 (2.63–10.22)<0.00017.524.62 (1.57–13.79)<0.0114.415.38 (2.56–12.83)0.0001
CMR results
 LVEF, per 10%22.580.95 (0.93–0.97)<0.00013.290.97 (0.9–1.01)0.0721.410.94 (0.91–0.96)<0.0001
 LV mass index, g/m212.721.03 (1.01–1.04)<0.00052.671.02 (0.99–1.05)0.1110.921.03 (1.01–1.05)<0.0005
 LVEDVi, per 10 ml/m220.841.02 (1.01–1.03)<0.00014.351.03 (1.01–1.06)<0.0516.391.02 (1.01–1.03)<0.0001
 LVESVi, per 10 ml/m228.251.02 (1.01–1.02)<0.00016.471.03 (1.01–1.05)0.0121.561.02 (1.01–1.03)<0.0001
 Resting RWMA28.317.06 (3.44–14.5)<0.000113.267.61 (2.55–22.67)<0.000516.067.94 (2.89–21.86)<0.0001
 LGE presence10.293.08 (1.55–6.11)0.0013.883.34 (1.01–11.1)<0.056.633.31 (1.33–8.24)0.01
 LGE mass, per gram of tissue4.731.02 (1.01–1.04)<0.050.91.03(0.97–1.08)0.343.461.02 (0.99–1.04)0.06
 LGE presence without Hx of MI9.624.3 (1.7–10.79)<0.0050.882.76 (0.33–22.97)0.348.415.74 (1.76–18.69)<0.005
 ISCHEMIA(+)34.5817.16 (6.65–44.25)<0.000114.1849.9 (6.52–381.67)<0.000114.9811.19 (3.29–38.03)<0.0001
 ISCH-SCORE62.121.19 (1.14–1.24)<0.000137.151.36 (1.23–1.5)<0.000125.951.14 (1.1–1.2)<0.0001

CI = confidence interval; HR = hazard ratio; LR = likelihood ratio; MACE = major adverse cardiac events; other abbreviations as in Table 1.

  • Could not be determined due to low event.